FP
TNDM icon

Foundry Partners’s Tandem Diabetes Care TNDM Stock Holding History

Foundry Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,569
Closed -$1.87M – 449
2020
Q4 		$1.87M Sell
19,569
-10,999
-36% -$1.13M 0.07% 290
2020
Q3 		$3.47M Sell
30,568
-330
-1% -$34.7K 0.17% 178
2020
Q2 		$3.06M Sell
30,898
-5,254
-15% -$419K 0.15% 188
2020
Q1 		$2.33M Buy
36,152
+8,050
+29% +$564K 0.13% 197
2019
Q4 		$1.68M Sell
28,102
-667
-2% -$41.1K 0.06% 284
2019
Q3 		$1.7M Sell
28,769
-62
-0.2% -$3.96K 0.07% 273
2019
Q2 		$1.86M Buy
+28,831
New +$1.86M 0.07% 268

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Foundry Partners's TNDM Position: Q1 2021 in Review

Foundry Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 19,569 shares — an estimated $1.87M sold.

Foundry Partners first reported a position in TNDM in Q2 2019 and held it in 7 quarters. The position peaked at $3.47M in Q3 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Foundry Partners reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • Foundry Partners sold 19,569 Tandem Diabetes Care shares in Q1 2021, an estimated $1.87M.
  • Foundry Partners first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 7 quarters.
  • Foundry Partners's Tandem Diabetes Care position peaked at $3.47M in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Foundry Partners's 13F filing for Q1 2021, filed 12 May 2021.